Cost-effectiveness of screening for hepatocellular carcinoma among subjects at different levels of risk

Journal of Evaluation in Clinical Practice

Volumn 17, Issue 2, 2011, Pages 261-267

  Chang, Yaojen ^a   Lairson, David R ^b   Chan, Wenyaw ^b   Lu, Sheng Nan ^c   Aoki, Noriaki ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d University of Texas School of Health Information Sciences at Houston   (United States)

Author keywords

Cirrhosis; Cost effectiveness; Hepatitis B virus; Hepatocellular carcinoma; ICER; Screening

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CANCER STAGING; COST EFFECTIVENESS ANALYSIS; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MORTALITY; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SENSITIVITY ANALYSIS; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; COST-BENEFIT ANALYSIS; EARLY DIAGNOSIS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED; RISK ASSESSMENT; TAIWAN;

EID: 79952662457     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2010.01432.x     Document Type: Article

References (36)

1. Liaw, Y. F., Sung, J. J., Chow, W. C., et al. (2004) Lamivudine for patients with chronic hepatitis B and advanced liver disease. New England Journal of Medicine, 351, 1521-1531.
2. Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y. & Tsai, J. H. (1997) Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. British Journal of Cancer, 76 (7), 968-974. (Pubitemid 27401953)
3. Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M. & Rode's, J. (2001) Clinical management of hepatocellular carcinoma Conclusions of the Barcelona-2000 EASL conference. Journal of Hepatology, 35, 421-430.
4. Yuen, M. F. & Lai, C. L. (2003) Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness. Annals of Oncology, 14, 1463-1467.
5. Sangiovanni, A., Ninno, E. D., Fasani, P., Defazio, C., Ronchi, G., Romeo, R., Morabito, A., Franchis, R. D. & Colombo, M. (2004) Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology, 126, 1005-1014. (Pubitemid 38451172)
6. Hsu, Y. S., Chien, R. N., Yeh, C. T., Sheen, I. S., Chiou, H. Y., Chu, C. M. & Liaw, Y. F. (2002) Long-term outcome after spontaneous HBeAg seroconversion seroconversion in patients with chronic hepatitis B. Hepatology, 35, 1522-1527.
7. Yu, M.W., Hsu, F. C., Sheen, I. S., Chu, C. M., Lin, D.Y., Chen, C. J. & Liaw, Y. F. (1997) Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. American Journal of Epidemiology, 145, 1039-1047.
8. Bruix, J. & Sherman, M. (2005) (AASLD Practice Guideline) Management of hepatocellular carcinoma. Hepatology, 42 (5), 1208-1236. (Pubitemid 43112690)
9. Franchis, R. D. & Dell'Era, A. (2007) Non-invasive diagnosis of cirrhosis and the natural history of its complications. Best Practice & Research. Clinical Gastroenterology, 21 (1), 3-18.
10. D'Amico, G., Garcia-Tsao, G. & Pagliaro, L. (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. Journal of Hepatology, 44 (1), 217-231. (Pubitemid 41772537)
11. Chen, M. F., Hwang, T. L., Jeng, L. B.,Wang, C. S., Jan, Y.Y. & Chen, S. C. (1994) Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Archives of Surgery, 129 (7), 738-742.
12. Llovet, J. M., Fuster, J. & Bruix, J. (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology, 30, 1434-1440.
13. Belghiti, J., Panis, Y., Farges, O., Benhamou, J. P. & Fekete, F. (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Annals of Surgery, 214 (2), 114-117.
14. Sheu, J. C., Sung, J. L., Chen, D. S., et al. (1985) Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology, 89, 259-266.
15. Yeh, C. N., Chen, M. F., Lee, W. C. & Jeng, L. B. (2002) Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. Journal of Surgical Oncology, 81 (4), 195-202.
16. Chen, M. F., Jeng, L. B. & Lee, W. C. (2002) Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan. World Journal of Surgery, 26 (6), 742-747.
17. Buscarini, L., Buscarini, E., Stasi, M. D., Vallisa, D., Quaretti, P. & Rocca, A. (2001) Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. European Radiology, 11 (6), 914-921. (Pubitemid 32755549)
18. Curley, S. A., Izzo, F., Ellis, L. M., Vauthey, J. N. & Vallone, P. (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Annals of Surgery, 232 (3), 381-391.
19. Yao, F.Y., Ferrell, L., Bass, N. M.,Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L. & Roberts, J. P. (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 33 (6), 1394-1403. (Pubitemid 32496976)
20. Attaphol, P., Narin, V., Virote, S., Pinit, K. & Yehuda, Z. (1998) Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. American Journal of Clinical Oncology, 21 (4), 386-391.
21. Yeung, Y. P., Lo, C. M., Liu, C. L., Wong, B. C., Fan, S. T. & Wong, J. (2005) Natural history of untreated nonsurgical hepatocellular carcinoma. The American Journal of Gastroenterology, 100, 1995-2004.
22. Mok, T. S., Yu, S. C., Lee, C., et al. (2004) False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels. American Journal of Roentgenology, 183 (2), 453-458. (Pubitemid 38970340)
23. Lin, S. M. (2009) Recent advances in radiofrequency ablation in the treatment of hepatocellular carcinoma and metastatic liver cancers. Chang Gung Medical Journal, 32 (1), 22-32.
24. Iloeje, U. H., Yang, H. I., Su, J., Jen, C. L., You, S. L. & Chen, C. J. (2006) Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology, 130, 678-686. (Pubitemid 43374518)
25. Chalasani, N., Horlander, J. C. Sr, Said, A., Hoen, H., Kopecky, K. K., Stockberger, S. M., Manam, R., Kwo, P. Y. & Lumeng, L. (1999) Screening for hepatocellular carcinoma in patients with advanced cirrhosis. The American Journal of Gastroenterology, 94 (10), 2988-2993. (Pubitemid 29482770)
26. Sherman, M., Peltekian, K. M. & Lee, C. (1995) Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology, 22 (2), 432-438.
27. Kubota, K., Ina, H., Okada, Y. & Irie, T. (2003) Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Digestive Diseases and Sciences, 48 (3), 581-586. (Pubitemid 36324168)
28. Taiwan Government, Ministry of Interior, Department of Statistics (2009) Life table list. Available at: http://www.moi.gov.tw/stat/english/life.asp (last accessed 23 September 2009).
29. International Monetary Fund (IMF) (2009) Data and statistic. Available at: http://www.imf.org/external/pubs/ft/weo/2009/02/weodata/weoselgr.aspx (last accessed 15 October 2009).
30. Sarasin, F. P., Giostra, E. & Hadengue, A. (1996) Cost-effectiveness of screening for detection of small hepatocellular carcinoma in Western patients with Child-Pugh class A cirrhosis. American Journal of Medicine, 101, 422-434. (Pubitemid 26392861)
31. Bolondi, L., Sofia, S., Siringo, S., Gaiani, S., Casali, A., Zironi, G., Piscaglia, F., Gramantieri, L., Zanetti, M. & Sherman, M. (2001) Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut, 48, 251-259. (Pubitemid 32141852)
32. Farinati, F. & Gianni, S. (2001) Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective? European Journal of Cancer Prevention, 10 (1), 111-115. (Pubitemid 32200213)
33. Yuen, M. F., Cheng, C. C., Lauder, I. J., Lam, S. K., Ooi, C. G. & Lai, C. L. (2000) Early detection of hepatocellular carcinoma in chronic increases the chance of treatment: Hong Kong experience. Hepatology, 31, 330-335. (Pubitemid 30078596)
34. Chen, C. J., Yang, H. I., Su, J., Jen, C. L., You, S. L., Lu, S. N., Huang, G. T. & Iloeje, U. H. (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus dna level. The Journal of the American Medical Association, 295 (1), 65-73. (Pubitemid 43042691)
35. Trevisani, F., Notariis, S. D., Rapaccini, G., et al. (2002) Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). The American Journal of Gastroenterology, 97 (3), 734-744. (Pubitemid 34245906)
36. Chen, H. H., Chen, C. J., Yen, M. F., Lu, S. N., Sun, C. A., Huang, G. T., Yang, P. M., Lee, H. S. & Duffy, S. W. (2002) Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. International Journal of Cancer, 98, 257-261.